SLP - Simulations Plus, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Simulations Plus, Inc.
Simulations Plus Inc is a developer of drug discovery and development software for mechanistic modelling, simulation and machine learning based technologies. It also explores the application of machine learning technologies in other industries.
IPO Date: June 19, 1997
Sector: Healthcare
Industry: Health Care Technology
Market Cap: $374.16M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.40 | 2.25%
Avg Daily Range (30 D): $0.02 | 0.12%
Avg Daily Range (90 D): $0.11 | 0.66%
Institutional Daily Volume
Avg Daily Volume: .08M
Avg Daily Volume (30 D): .17M
Avg Daily Volume (90 D): .3M
Trade Size
Avg Trade Size (Sh.): 69
Avg Trade Size (Sh.) (30 D): 134
Avg Trade Size (Sh.) (90 D): 91
Institutional Trades
Total Institutional Trades: 1,406
Avg Institutional Trade: $1.2M
Avg Institutional Trade (30 D): $1.24M
Avg Institutional Trade (90 D): $1.67M
Avg Institutional Trade Volume: .04M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.2M
Avg Closing Trade (30 D): $2.05M
Avg Closing Trade (90 D): $1.28M
Avg Closing Volume: 34.97K
 
News
Sep 23, 2026 @ 9:58 AM
Biosimulation Market Set for Strong Growth Through...
Source: Researchandmarkets.Com
Aug 6, 2026 @ 2:53 PM
Johnson Fistel Investigates Simulations Plus Follo...
Source: Johnson Fistel, Pllp
Jul 10, 2026 @ 8:43 PM
Halper Sadeh LLC is Investigating Whether SLP, HUN...
Source: Halper Sadeh Llc
Jul 8, 2026 @ 6:35 PM
Halper Sadeh LLC is Investigating Whether CRNX, ES...
Source: Halper Sadeh Llc
Jun 26, 2026 @ 6:30 AM
[Latest] Global In Silico Clinical Trials Market S...
Source: Healthcare Foresights
Financials
  TTM Q3 2026 Q2 2026
Basic EPS $.41 $.18 $.22
Diluted EPS $.4 $.18 $.22
Revenue $82.06M $21.89M $24.29M
Gross Profit $52.01M $15.13M $16.14M
Net Income / Loss $8.11M $3.58M $4.54M
Operating Income / Loss $11.5M $4.5M $5.63M
Cost of Revenue $30.05M $6.76M $8.15M
Net Cash Flow $8.37M $9.6M $-4.46M
PE Ratio    
Splits
Oct 02, 2007 2:1
Aug 14, 2006 2:1